Skip to main content
. 2020 Mar 26;8(1):e000548. doi: 10.1136/jitc-2020-000548

Figure 1.

Figure 1

[89Zr]Zr-N-suc-Df-ERY974 distribution in time. (A) Maximal intensity projection images of [89Zr]Zr-N-suc-Df-ERY974 in HepG2 tumor (white dotted circle) bearing NOG mice at 24 hours, 72 hours, 120 hours and 168 hours post 10 µg [89Zr]Zr-N-suc-Df-ERY974 injection. (B) Quantification of tumor and blood pool (n=6). data shown as median SUVmean and IQR. (C) Tumor-to-blood ratio based on SUVmean. Data shown as median tumor-to-blood ratio and IQR. Cr, cranial; Ca, caudal; H, heart; L, liver; SUVmean, standardised uptake value; T, tumor.